Investor Relations

English Español Português Deutsch

Khiron Increases Clinical Capacity in Colombia by 75% with Opening of Zerenia Integrated Medical Clinic

View Press Release View All

Jan 6, 2020 • 12:01 AM EST

Khiron CEO Alvaro Torres to Present at AltaCorp/ATB 8th Annual Institutional Investor Conference

Dec 30, 2019 • 12:01 AM EST

Khiron Welcomes Colombia's Receipt of 2020 Production Quota of 56.5 Tons of High-THC Cannabis

Dec 16, 2019 • 12:01 AM EST

Khiron Welcomes Regulatory Guidelines in Peru, Announces Good Storage Practices Certification

View Presentation

Recent Events

Jan 15, 2020 • 12:00 pm - 1:30 pm EST

Khiron Investors Luncheon - Toronto

View Event

Jan 14, 2020 • 3:10 pm EST

AltaCorp/ATB 8th Annual Institutional Investor Conference

View All

Q3 2019

Quarter Ended Sep 30, 2019

Earnings Release

PDF HTML

Financial Statements

PDF

MD&A

PDF

Company Overview

Khiron Life Sciences is a Latin American Cannabis Company with Global Growth with its core operations in Colombia. Khiron combines leading international scientific expertise, agricultural advantages and branded product market entrance experience to address the unmet medical needs in a market of over 620 million people in LatAm.

View Management Team View Board of Directors

Investor Contact Information

Company

Khiron Life Sciences Corp.
100 King Street West
Suite 1600
Toronto, Ontario M5X 1A9
Canada